Patents
Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
09/2008
09/18/2008CA2679526A1 Nitroxides for lithium-ion batteries
09/17/2008CN101265322A Cyano-containing benzoxazine intermediate and resin thereof
09/17/2008CN101265262A New oxabispidine compounds useful in the treatment of cardiac arrhythmias
09/16/2008US7425554 1,2-di(cyclic)substituted benzene compounds
09/16/2008CA2515338C Inhibitors of histone deacetylase
09/12/2008WO2008108630A1 Polymorphic forms of efavirenz
09/11/2008US20080221083 Heterobicyclic metalloprotease inhibitors
09/10/2008EP1966132A2 Compounds which modulate the cb2 receptor
09/09/2008US7423147 Therapy of Histamine H3 receptor mediated diseases
09/09/2008US7423146 Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
09/09/2008US7423067 Diphenyl cyclopentyl amides as cannabinoid-1 receptor inverse agonists
09/09/2008US7423037 Morpholine derivatives as norepinephrine reuptake inhibitors
09/09/2008US7423035 e.g. 5-hydroxy-8-{1-hydroxy-2-[1-(4-methoxy-benzyl)-cyclopropylamino]-ethyl}-4H-benzo[1,4]oxazin-3-one; mimetics of beta-adrenergic substances; beta 2-adrenoceptor modulator; antiinflammatory agent; chronic obstructive respiratory diseases; longer duration of activity
09/04/2008WO2008106128A2 CYCLIC UREA AND CARBAMATE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1
09/04/2008WO2008042755A3 Inhibitors of cognitive decline
09/04/2008US20080210907 Gelling agent, carbon nanotubes aqueous dispersing agent; simple synthesis from low cost, readily available raw materials; rapid elastic modulus recovery; environmentally friendly
09/04/2008CA2678577A1 Cyclic urea and carbamate inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
09/03/2008EP1963287A1 Glucocorticoid receptor modulators as antiinflammatory agents
09/02/2008US7420054 Leucine-9-aminobenzo[a]phenoxazin-5-one; use thereof for the detection and/or identification and/or quantification of microorganisms expressing at least one peptidase activity, microbiology, biochemistry, immunology, molecular biology, histology
09/02/2008US7420043 Reagents for detecting efavirenz
09/02/2008US7419969 N-((hetero)arylalkyl)pyrimidonecarboxamides in which the ring is fused to a C4-7(hetero)cycloalkyl ring, which in turn has a spiro ring attached: e.g., N-[(4-fluorophenyl)methyl]-7',8'-dihydro-3'-hydroxy-8'-methyl-4'-oxo-spiro[cyclopentane-1,9'(6'H)-[4H]pyrazino[1,2-a]pyrimidine]-2'-carboxamide
09/02/2008US7419967 e.g. hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-3-(cyclopentyloxy)[(3-[2-(dimethylamino)ethyl]aminophenyl)sulfonyl]amino-2-hydroxypropyl)carbamate; against human immunodeficiency virus, chronic and acute viral infections
09/02/2008CA2411412C Indole derivatives useful for the treatment of cns disorders
09/02/2008CA2273023C Aminoguanidines and alkoxyguanidines as protease inhibitors
08/2008
08/28/2008WO2008059513A3 Compounds suitable as modulators of hdl
08/28/2008US20080207622 Soluble epoxide hydrolase inhibitors
08/28/2008US20080207621 Use treating hypertensive, cardiovascular, inflammatory, pulmonary, and diabetes-related diseases; compounds are aminosulfonylphenyl urea or thiourea e.g. 4-(3-Adamantan-1-yl-ureido)-N-(2-morpholin-4-yl-ethyl)-benzenesulfonamide
08/28/2008US20080207607 Antiarthritic agents; antiinflammatory agents; arteriosclerosis; multiple sclerosis
08/27/2008CN101253147A Organic compounds
08/26/2008US7417041 Imidazopyrimidines as transforming growth factor (TGF) inhibitors
08/21/2008WO2008053393A8 Rotary actuator
08/21/2008WO2007037898A8 Theramutein modulators
08/21/2008US20080200466 Organic Compounds For the Treatment of Inflammatory or Allergic Conditions
08/21/2008US20080200461 Use as agricultural pesticide, fungicide, herbicide, also a pharmaceutical, for treating obesity, metabolic syndrome, atherosclerosis, cardiovascular disease and insulin resistance, diabetes, fungal infections; compounds are diamines or derivatives, with at least one tert-amine or quaternary ammonium
08/21/2008US20080200457 4-Cyclopropyl-1,2,3,-Thiadiazole Compound, Agrohorticultural Plant Disease Controlling Agent And Method Of Using The Same
08/21/2008US20080196300 against the action of light, oxygen and heat; fuel additive in turbine fuels, jet fuels; heat resistance, oxidation resistance, photostability; water separation, water compatibility
08/21/2008US20080196177 Unsubstituted and polymeric fluoran colorants for coloring consumer products
08/21/2008US20080196176 Unsubstituted and polymeric lactone colorants for coloring consumer products
08/20/2008EP1957462A2 Novel 2-amino-heterocycles udeful in the treatment of abeta-related pathologies
08/20/2008EP1249233B1 Npyy5 antagonists
08/20/2008CN101248066A Non-steroidal progesterone receptor modulators
08/20/2008CN101248062A C-fms kinase inhibitors
08/20/2008CN101248037A Process for preparing enantiomerically enriched beta-amino acid derivatives
08/20/2008CN100412075C Process for preparing L-ofloxacin and ofloxacin
08/19/2008US7414128 Crystalline R-guanidines, Arginine or (L)-Arginine (2S)-2-Ethoxy-3-{4-[2-(10H -phenoxazin-10-yl)ethoxy]phenyl}propanoate
08/19/2008US7414053 cyclin-dependent and serine/threonine kinases inhibitor; cell cycle arrest in the G2/M phase; antiproliferative and antitumor agent: leukemia, sarcoma, lung, breast, prostate, pancreas cancer; autoimmune diseases: arthritis, Alzheimer's disease
08/19/2008US7414052 1-(2,3-dihydro-4H-1,4-benzoxazin-4-yl)-3-(methylamino)-1-phenylpropan-2-ol; fluctuations of sex steroid lelels; monoamine reuptake modulator; antidepressant, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue and fibromylagia syndrome, stress and urinary incontinence
08/14/2008WO2008063794A3 Oxazolidinium compounds and use as hydrate inhibitors
08/14/2008US20080194816 Method of producing an o-disubstituted aromatic compound, and method of producing a monosubstituted-monohaloaromatic compound
08/14/2008US20080194564 the use thereof for the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions comprising them, and processes for the preparation of these
08/14/2008US20080194551 Acetylene Derivatives
08/14/2008US20080194550 optical isomer thereof, or a corresponding acid addition salt thereof with a pharmacologically acceptable acid, and the use thereof as pharmaceutical compositions, particularly for the treatment of inflammatory and obstructive respiratory complaints.
08/13/2008EP1956012A1 Method for producing 2-oxazoline analogue or 1,3-oxazine analogue
08/13/2008EP1955697A1 2-aminobenzamide derivative
08/13/2008EP1954132A2 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
08/13/2008EP1753763B1 Indazole and indolone derivatives and their use as pharmaceuticals
08/13/2008CN101239945A Aminoquinoline derivatives and their use as adenosine a3 ligands
08/12/2008US7410990 Heterocyclic compounds
08/12/2008US7410971 1,2-di(cyclic)substituted benzene compounds
08/12/2008CA2359819C 2-oxy-benzoxazinone derivatives for the treatment of obesity
08/07/2008WO2008094496A1 Detection of platinum group metals with fluorophores via allylic oxidative insertion
08/07/2008US20080188654 Compounds for treatment of inflammation, diabetes and related disorders
08/07/2008US20080188448 reduced antiglucocorticoid effects; side effect reduction; endometriosis, leiomyomas of the uterus, dysfunctional bleeding, dysmenorrhoea; antitumor agents; female fertility control, for hormone replacement therapy; 6-[2(2,2-Dimethylpropyl)-2-hydroxypent-3-ynoylamino]-4-methyl-2,3-benzoxazin-1-one
08/05/2008US7408060 Nonsteroidal progesterone receptor modulators
07/2008
07/31/2008WO2008090193A2 Method for producing betamimetics
07/31/2008WO2008042896A3 Tetra-substituted ndga derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use
07/31/2008CA2675094A1 Process for the manufacturing of beta mimetics
07/30/2008EP1949908A1 Combined use of derivatives of GLP-1 analogs and PPAR ligands
07/30/2008EP1948626A1 Process for the preparation of delmopinol and derivatives thereof
07/30/2008EP1948625A1 Process for the preparation of betamimetic benzoxazinone derivatives
07/30/2008EP1948623A2 Heterocyclic amide derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes
07/30/2008EP1948607A2 Cyclopropyl amines as modulators of the histamine h3 receptor
07/30/2008EP1592684B1 Malonamide derivatives as gamma-secretase inhibitors
07/30/2008CN101230008A Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
07/29/2008CA2284653C Tetraaza- or n2s2- complexants, and their use in radiodiagnostics or radiotherapy
07/24/2008WO2007035425A3 Cyclopropyl amines as modulators of the histamine h3 receptor
07/24/2008US20080177066 reacting 2-chloro-sustituted pteridinones with para-aminobenzamides in the presence of acid catalysts, to form pteridinone derivatives having antiproliferative activity
07/24/2008US20080176843 Modulators of muscarinic receptors
07/24/2008US20080175795 e.g. 3-{4-[4-(2-amino-2-carbamoyl-ethyl)-phenoxy]-phenyl)-propionic acid; antiinflammatory and immunological diseases, cytokines (TNF- alpha , IL-1, IL-6), orexin, nitric oxide synthase inhibitor; obesity, hyperlipidemia, migraine, asthma, chronic obstructive pulmonary disease, osteoarthritis
07/23/2008EP1947093A1 Substituted morpholine and thiomorpholine derivatives
07/23/2008CN101228142A Intermediate compound for synthesizing pharmaceutical agent and production method thereof
07/23/2008CN101228141A Tetrahydrobenzoxazines as stabilisers
07/22/2008US7402698 1-[2-(benzylamino)-1-(3,4-dichlorophenyl)ethyl]cyclobutanol hydrochloride; norepinephrine reuptake inhibitor; antidepressant, analgesic; vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, sleep disorder, hormone replacement syndrome
07/22/2008US7402598 Arylethanolamine β2-adrenoreceptor agonist compounds
07/22/2008US7402579 Quinobenzoxazine analogs and compositions
07/17/2008WO2007092961A3 Antibacterial agents
07/17/2008US20080171874 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines
07/17/2008US20080171681 3-(2-hydroxyphenyl)-2-propenamides that react to form a lactone and an amine; laundry detergents, perfumes, shampoos and hair conditioners
07/16/2008CN100402511C 6-aryloxymethyl-4-aryl-3-morpholone derivative and its preparation method
07/16/2008CN100402501C Aminoquinoline derivatives and their use as adenosine A3 ligands
07/10/2008WO2008053393A3 Rotary actuator
07/10/2008US20080167311 Glaucome therapy; vision defects
07/10/2008US20080167299 menopause therapy; contraceptive; anticancer agents
07/10/2008US20080167298 Medicaments for the treatment of chronic obstructive pulmonary disease
07/09/2008EP1942105A1 Aminodihydrothiazine derivative
07/09/2008EP1940810A2 Inhibitors of phosphodiesterase type-iv
07/09/2008EP1940387A1 Process for the stereoselective preparation of (-)-halofenate and intermediates thereof
07/09/2008EP1594853B1 Method for the production of bicyclic aromatic amino acids and intermediate products thereof
07/09/2008CN100400523C Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
07/09/2008CN100400522C Novel charge transport materials having heteroaromatic hydrazone groups
1 ... 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 ... 112